Interpace Biosciences Market Cap

Interpace Biosciences has a market cap or net worth of $11.66 million as of December 27, 2024. Its market cap has increased by 124.89% in one year.

Market Cap

11.66M

Enterprise Value

63.27M

Revenue

44.89M

Ranking

n/a

PE Ratio

2.39

Stock Price

$2.65

Market Cap Chart

Since May 20, 1998, Interpace Biosciences's market cap has decreased from 221.97M to 11.66M, a decrease of -94.75%. That is a compound annual growth rate of -10.48%.

Market Cap History

Date	Market Cap	% Change
Dec 27, 2024	11.66M	148.52%
Dec 29, 2023	4.69M	5.76%
Dec 30, 2022	4.44M	-85.77%
Dec 31, 2021	31.18M	145.72%
Dec 31, 2020	12.69M	-33.55%
Dec 31, 2019	19.10M	-16.51%
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro
Dec 31, 2014	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sandoz Group AG	18.07B
Telix Pharmaceuticals Limited	5.22B
Elekta AB (publ)	2.09B
Ryman Healthcare Limited	1.72B
Verano Holdings Corp.	463.76M
Vireo Growth Inc.	129.65M
Medexus Pharmaceuticals Inc.	55.68M

Market Cap Rankings